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PREFACE 
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Research performed with Dr. Nicholas Reo, Wright State University, under Henry M. Jackson 
Foundation sub-award HJF 132633, contract FA8650-05-2. 
 
The protocol involving human research subjects (F-WR-2010-0029-H) was approved by the 
Wright-Patterson Institutional Review Board (IRB), and was conducted at Brooks City-Base 
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Biobehavioral, Bioassessment, and Biosurveilance Branch. 
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1.0  SUMMARY 
 
 
The sleep deprivation-induced fatigue susceptibility ranking portion of the cognitive fatigue 
study seeking to determine metabolic biomarkers for resistance to sleep deprivation-induced 
cognitive fatigue was completed at Brooks City-Base, TX in 2010. A total of 23 subjects 
completed a sleep-deprivation induced fatigue protocol involving informed consent, medical 
screening, two-day evening training on cognitive tasks, providing five urine samples (beginning 
with a morning 12 h pre-study baseline), refresher training, and an experimental session (with 
six, four hour long blocks) starting in the evening. Subjects demonstrated the expected declines 
in performance during the 36-hour, 15-minute period of sleep deprivation without caffeine. The 
simple change from baseline results on the Psychomotor Vigilance Task (PVT) was 
recommended as the primary classifier for cognitive fatigue susceptibility. The Automated 
Neuropsychological Assessment Metrics-Math, Continuous Performance Test (CPT), and 
Grammatical Reasoning (ANAM-core), developed by the US Army, was also implemented with 
the math component recommended as the secondary classifier for cognitive fatigue susceptibility 
(Harville et al., 2010). The details of the first phase of the cognitive fatigue study involving 
psychological computer testing in which study participants were ranked according to their 
cognitive fatigue susceptibility, based on their behavior observed during sleep deprivation, was 
described in technical report AFRL-RH-WP-TR-2010-0150 entitled: “Biomarkers of Fatigue: 
Ranking Mental Fatigue Susceptibility (Harville et al, 2010).” The present report describes the 
second phase of the study involving nuclear magnetic resonance (NMR) spectroscopy-based 
metabolomics analysis of urine samples collected from these same study subjects to determine if 
metabolite profiles, or biomarkers, could be used as a predictor of cognitive fatigue susceptibility 
in military personnel prior to selection for demanding missions. 
 
Urine is a noninvasively-collected, information-rich biofluid that can provide insight into the 
metabolic state of an organism. As a result, urine is often a focus in metabolomics investigations 
using NMR and liquid chromatography/mass spectroscopy (LC/MS) analyses. Targeted profiling 
is a powerful tool that can drive such studies, providing direct identification and quantification of 
a variety of potential metabolite biomarkers. This approach has been demonstrated previously in 
animal toxicity studies. Statistically significant group classification based on NMR spectral 
analysis has been previously shown in a metabolomics study investigating the susceptibility of 
rats to acetaminophen toxicity (Clayton et al., 2006). This work described an alternative and 
conceptually new 'pharmaco-metabonomic' approach to personalizing drug treatment that used a 
combination of pre-treatment metabolite profiling and chemometrics to model and predict the 
responses of individual subjects. This study was able to predict sensitivity/resistance to 
acetaminophen toxicity in rats prior to exposure to the compound. 
 
Preliminary results from a previous sleep deprivation study indicated that urinary metabolite 
profiles (biosignatures) identified using NMR and LC/MS analyses were able to classify subjects 
with respect to cognitive performance during sleep-deprivation induced fatigue.  Results 
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obtained from this previous cognitive fatigue study also indicated that pre-study NMR spectral 
profiling of human urine, along with chemometric analysis, was capable of predicting cognitive 
fatigue susceptibility prior to testing (data not reported). 
 
The purpose of the second phase of the current cognitive fatigue research is to identify degree of 
fatigue resistance/sensitivity and to anonymously identify urinary biomarkers (metabolites) 
associated with fatigue resistance/sensitivity.  Recent advances in our laboratory’s bioinformatics 
tools development for multivariate statistical analysis of NMR-based metabolomics data has 
resulted in more accurate biosignature and biomarker identification (Anderson et al. 2011). In the 
present study, bioinformatic analysis of NMR data indicated that urinary metabolite profiles 
could discern differences in cognitive performance of study subjects 12 h prior to cognitive 
testing, and of subjects that were sleep-deprived for 28 h. Furthermore, psychological cognitive 
testing scores (i.e. PVT and ANAM-core), with regards to classification as cognitively resistant 
or sensitive to sleep deprivation-induced fatigue, were found to correlate with urinary metabolite 
profiles determined at 28 h of sleep deprivation. Although significant urinary metabolite profile 
differences were observed by NMR analysis 12 h prior to the start of the psychological testing 
phase of the study between two cohort subset group classifications, with respect to cognitive 
performance, no differences in cognitive performance were noted via psychological testing at 
this time point. 
 
Using a Chenomx database analysis of processed NMR data, we identified twenty three 
metabolite spectral peaks that were significant in separating two subsets of 23 human subjects; 
one that was cognitively resistant (n = 6) and one cognitively sensitive (n = 6) to sleep 
deprivation. Seven of the 23 NMR spectral peaks could not be assigned a metabolite 
identification using the Chenomx database. Fourteen of the 23 peaks were statistically significant 
(p ≤ 0.05) in distinguishing between the two fatigue classification groups. Five of these 14 
metabolites could not be identified. The other nine metabolites were identified and a number of 
these were noteworthy. These included: tyrosine, homovallinate, 3-hydroxyisovalerate, alanine, 
2,2-dimethylsuccinate and taurine. Tyrosine and homovanillate are metabolites associated with 
the dopaminergic pathway and were elevated in the urine of the fatigue-resistant subjects. This 
pathway has been shown to be associated with a more awake state. Alanine, 2,2- 
dimethylsuccinate and taurine were elevated in the urine of fatigue-sensitive subjects and can be 
linked to high percentage dietary carbohydrate intake that has been found to be associated with 
inducing sleepiness. Self-recorded food logs from the subjects 8 h prior to the cognitive testing 
phase indicated that those who were more resistant to sleep deprivation-induced fatigue ingested 
significantly (2-fold) higher amounts of protein prior to testing.  It is possible that using this 
profile of 14 metabolite peaks that the risk of cognitive decline in demanding missions may be 
predicted and may be associated with nutritional status. 
3 
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Identification of urinary biosignatures (spectral profile) of cognitive fatigue may provide for a 
real-time predictive screen of cognitive performance ability in defined and undefined mission 
environments for preventing or minimizing mission degradation due to cognitive impairment, as 
well as to aid in personnel selection for demanding missions. Furthermore, nutritional 
intervention may yield a non-pharmacological solution to countering the effects of sleep- 
deprivation induced fatigue on cognitive performance during demanding military missions. 
Future studies determining the effects of various dietary components and composition, as well as 
determining optimal time following ingestion, using larger cohorts of human subjects will be 
needed to validate the initial results of the present study. 
 
The results of this study lead to a working hypothesis and may be useful for developing new 
methods to rapidly assess and alter an individual’s cognitive status. We hypothesize that the 
nutritional status and subsequent metabolite profile is directly correlated with cognitive 
performance and fatigue resistance. Further, we suggest that NMR-based urinary metabolomics 
is a powerful tool to assess the nutritional status of individuals for optimal cognitive performance 
(i.e. mapping coordinates of an individual’s urinary metabolite profile can be visualized 
graphically in reference to coordinates indicative of a formulated fatigue index). This 
information can then be used to make appropriate adjustments to the diet, while monitoring the 
trajectory plot of the metabolite profile until a desired outcome is reached. 
4 
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2.1 INTRODUCTION 
 
 
2.2 Military Fatigue 
Most humans require approximately 8 h of sleep to maintain optimal cognitive function when 
awake (Anch et al., 1988). It is also well established that fatigue and cognitive performance are 
linked. Vigilance tasks have been shown to be very sensitive to fatigue induced by sleep 
deprivation, and result in cognitive performance degradation (Belenky et al., 2003; Driskell et 
al., 1991; Driskell and Salas, 1996; Hursh and Bell, 2001; Van Dongen et al., 2003). Research 
has also shown that the effects of fatigue directly impact vigilance, mood and cognitive 
performance (Krueger, 1991). Persistent sleep deprivation also contributes to both central and 
peripheral fatigue. Sleep deprivation has also been shown to have an impact on physical 
performance (Belmont et al., 2009).  When compared to well-rested individuals, sleep deprived 
individuals perform cognitive and physical tasks more slowly and have problems with memory. 
 
Because cognition is more significantly affected than psychomotor proficiency, decision making 
in flight operations can be problematic and lead to increases in errors and accidents (Caldwell et 
al., 2001; Billings et al., 1968; Pereli, 1980; Krueger, et al., 1985). Although the impact of 
fatigue on flight operations and our scientific understanding of fatigue and the factors involved 
are well known, fatigue related problems in flight operations continue to persist in both military 
and commercial aviation (Dinges et al., 1996). Consequently, the problems of pilot fatigue, and 
fatigue-related concerns regarding aviation safety, have been increasing over time. Even though 
there is staggering evidence that sleep deprivation has significant detrimental effects on 
performance, military culture evokes the warfighter mentality that it can be overcome by proper 
motivation. This belief is contrary to the reality that the warfighter needs adequate sleep to 
perform optimally. 
 
Continuous and sustained actions in operational environments typically leads to reduction in the 
amount of sleep required to perform optimally. These operational environments subject the war 
fighter to intense physical and mental exertion. Other factors present in these environments that 
impact war fighter performance include, reduced caloric intake, dietary changes, and decision- 
making induced stress.  Aircrews are particularly susceptible to the effects of fatigue due to 
mission-related extended duty hours and irregular sleeping patterns. Rotating shifts, maintenance 
delays and mission rescheduling can lead to disruptions in normal sleep cycles in pilots and 
ground crews causing performance decrements that can have dire consequences on mission 
effectiveness (Australian Government Civil Aviation Safety Authority, 2004). The Air Force 
(Luna, 2003; Nicholson et al., 1986), the Army (Caldwell and Gilreath, 2002; Caldwell and 
Gilreath, 2001), and the Navy (Belland and Bissell, 1994; Ramsey et al., 1997) have all reported 
that sleep deprivation-induced fatigue is a significant problem that has resulted in performance 
degradation. This creates a situation where a routine task can suddenly evolve into an event with 
lethal consequences. 
5 
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Because fatigue has been shown to be an occupational hazard, leading to cognitive defects in 
performance, there has been a recognized need for real-time detection technologies that 
minimize fatigue-induced mishaps (Brown, 1997). Efforts have been made to detect real-time 
fatigue in pilots using prudent technologies in an attempt to develop and implement effective 
countermeasures. Although it has been established that changes in electroencephalography 
(EEG) brain waves are a valid means of assessing fatigue, such assessments are not practical. 
Furthermore, the validity of an automated technology, such as EEG, may not be legitimate in 
another operational environment. Therefore, their usefulness is dependent on the requirements 
and conditions of the operational environment (i.e. flight line or cockpit). Currently, none of the 
fatigue detection technologies developed has been adequately verified in an operational 
environment. 
 
 
2.3 Nutrition 
Maintaining good nutrition is an important factor for both physical and cognitive performance. It 
has been demonstrated that normal variations in nutrition have little effect on sleep anatomy 
(Lucero and Hicks, 1990; Neumann and Jacobs, 1992); unusual variations in diet may produce 
mild effects. Severe reduction in dietary intake can lead to sleep disruption and fatigue. Failure 
to maintain sufficient glucose levels in the blood will result in a situation that is not promotive of 
restful sleep and can lead to poor cognitive performance. In fact, diets high in carbohydrates 
prior to bedtime have been shown to be linked to inducing sleepiness (Porter and Horne, 1981). 
 
The central nervous system (CNS) requires a number of amino acids found in food to function 
adequately (Betz et al., 1994). The importance of various amino acids as precursors for key brain 
neurotransmitters is well established, and transport mechanisms exist to provide these to the 
brain (Lieberman 1999). The functional implication of this unique characteristic of the blood- 
brain barrier (BBB) is that the amino acid composition of food is of greater consequence to the 
brain than perhaps any other organ system. Results from several lines of related research suggest 
that the peripheral concentration of particular amino acids can be a factor in the regulation of 
central neurotransmission, cognitive performance, and mood state; two of these amino acids, 
tryptophan and tyrosine, are of particular interest. 
 
Tryptophan is an essential amino acid found in food that is a precursor of the neurotransmitter 
serotonin. The highest levels of serotonin are typically observed in the hypothalamus and cortex 
following a pure carbohydrate meal. Serotonin is involved in the regulation of sleeping and 
waking (Portas et al., 2000), and ingestion of a mixture lacking tryptophan has been shown to 
shorten the sleep cycle (Moja et al., 1984; Voderholzer et al., 1998). Furthermore, it has been 
shown that severely undernourished soldiers perform poorly on cognitive tasks (Lieberman et al., 
1997). However, as the concentration of protein in a meal increases the brain concentration of 
6 
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serotonin falls. Studies suggested that increasing the amount of tyrosine in the diet causes an 
increase in brain catecholaminergic neurotransmission leading to a more awake state (Lieberman 
1994). 
 
Tyrosine is not considered an essential amino acid because it can be synthesized from 
phenylalanine in humans. Furthermore, protein foods typically contain higher levels of tyrosine 
compared to tryptophan. Tyrosine, a precursor of the neurotransmitters norepineprine, 
epinephrine and dopamine, enhances cognitive performance in animals (Ahlers, et al., 1994; 
Rauch and Lieberman, 1990; Shukitt-Hale et al., 1996; Shurtleff et al., 1993) and in humans 
under both physical and psychological stress (Banderet and Lieberman, 1989; Shurtleff et al., 
1994; Deijen and Orlebeke, 1994). 
 
 
2.4 Metabolomics 
Metabonomics is defined as “the quantitative measurement of the time-related multiparametric 
metabolic response of living organisms to pathophysiological stimuli or genetic modification” 
(Nicholson et al., 1999). The field of metabonomics is concerned with the study of fixed cellular 
and biofluid concentrations of endogenous metabolites, as well as dynamic metabolite 
fluctuations, exogenous species, and molecules that arise from chemical rather than enzymatic 
processing (Lindon et al., 2003). Metabonomics is an approach used to characterize the 
metabolic profile of a specific tissue or biofluid. Because many biofluids can be easily obtained 
either non-invasively (urine) or minimally invasively (blood), they are typically used in 
metabonomic studies. Metabolic alterations in various biofluids are expressed as “fingerprints” 
of biochemical perturbations that are characteristic of the type of stressor (biological, 
psychological, chemical, etc.) and target tissue insult (brain, liver, kidney, etc.). These metabolic 
alterations are often seen in the urine as changes in metabolic profile in response to the types of 
stressors or insults mentioned above. 
 
Metabolomics is a powerful tool for assessing the overall physiology of an organism. Because 
metabolomics measures the results of a multitude of biochemical and environmental 
interactions within an organism, it serves as a good indicator of an organism’s phenotype. 
Therefore, metabolomics allows for quantitative assessment of molecular phenotype in 
research studies. 
 
The most common analytical platforms used today in metabonomics are proton NMR, and mass 
spectroscopy (MS) coupled to liquid chromatography (LC) and gas chromatography.  The 
advantages of NMR-based metabonomics include being a nondestructive analysis, applicable to 
intact biomaterial, and information-rich with respect to determinations of molecular structure, 
especially in complex mixtures. The non-selectivity, lack of sample bias and reproducibility of 
NMR (Keun et al. 2002) is of critical importance when considering screening applications. 
7 
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Changes in NMR-derived urinary metabolite levels have proven to be a sensitive indicator of 
chemical-induced toxicity (Robertson et al., 2000; Holmes and Shockcor, 2000; Waters et al., 
2002; Nicholson, et al., 2002). MS offers the ability to detect chemical classes not detected by 
NMR (i.e. sulfates), and the capability to detect lower abundance metabolites with little sample 
processing. This is of critical importance if one is searching for novel biosignatures (or 
biomarkers) of physiological, psychological or chemical insult. Therefore, MS is complementary 
to NMR data and facilitates metabolite identification. 
 
The mammalian metabolome is comprised of both endogenous and exogenous metabolites. 
The latest version of the Human Metabolome Database (v. 2.5; released August, 2009) includes 
approximately 8,000 identified mammalian metabolites, with over 1,000 of these metabolites in 
the Human Metabolome Library (www.hmdb.ca). Endogenous metabolites are small molecules 
that are produced by the host genome, whereas exogenous metabolites, also known as 
xenometaboloites, are "foreign" substances derived from food, drugs or host-specific microbes. 
Endogenous metabolites vary little between species (i.e. rats, mice, humans, etc.). However, 
compared to exogenous metabolites, the number of endogenous metabolites is relatively small. 
The large number of exogenous metabolites is reflected by the highly varied diet of mammals 
that includes ingestion of a wide spectrum of animal, plant and microbe products. Further adding 
to the complexity of the exogenous metabolite pool is the inclusion of drugs, nutraceuticals, and 
other xenobiotics. In addition, metabolites from gut microflora offer another important source 
of exogenous metabolites. 
 
Urine is the only biofluid where the entire accumulation of water-soluble metabolites can be 
found.  This makes urine the ideal biofluid for metabolite analysis. Although urine cannot be 
sampled continuously, such as blood, it can be obtained in copious amounts and by non- 
invasive means. However, urine analysis only reflects metabolic events that occurred at an 
earlier time during host genome processing (i.e. gene and protein expression). While it is 
possible to maintain experimental control over diet and environment in animal studies, it is 
essentially impossible in the case of human studies. However, utilizing specialized diets and 
dietary restrictions (i.e. eliminating specific confounding food items, drugs, smoking) one can 
partially control for the variations intrinsically associated with human subjects. Furthermore, 
utilization of food/beverage intake logs can also further reduce this variability. These dietary 
issues can also be minimized by incorporating over-night fasting into the experimental design. 
 
The rational for performing metabolomics analysis in the current cognitive fatigue study is based 
on preliminary analysis of NMR data of human urine collected in a previous cognitive fatigue 
study in 2005 (data not reported). Preliminary NMR-based metabonomics results from this study 
indicated that distinctive urinary profiles (or biosignatures) were identified that could distinguish 
fatigue-susceptibility prior to being placed on-study. This finding was supported by previous 
metabolomics work investigating susceptibility to acetaminophen toxicity in rats (Clayton et al., 
2006). This work described an alternative and conceptually new 'pharmaco-metabonomic' 
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approach that used a combination of pre-dose metabolite profiling and chemometrics to model 
and predict the responses of individual subjects. Results obtained from the previous cognitive 
fatigue study also indicated that pre-study NMR profiling of human urine, along with 
chemometric analysis, was capable of predicting cognitive performance outcome under sleep 
deprivation-induced fatigue prior to testing.  Identification of urinary biosignatures predictive of 
fatigue susceptibility may provide for a real-time screen of cognitive/physical performance 
ability in defined and undefined mission environments for preventing or minimizing mission 
degradation due to cognitive/physical impairment, as well as to aid in personnel selection for 
demanding missions. 
 
 
3.1 MATERIALS AND METHODS 
 
In the present study, a total of 23 human subjects were recruited.  The human-use protocol (F- 
WR-2010-0029-H) for the cognitive fatigue research project was approved by the Wright- 
Patterson Institutional Review Board, and was conducted at Brooks City-Base, San Antonio, 
Texas under the direction of Dr. Donald Harville, Biosciences and Performance Division, 
Biobehavioral, Bioassessment, and Biosurveilance Branch. Human subjects were subjected to 
pre-study dietary restrictions as outlined in the “Informed Consent Document” (ICD) and 
maintained food and fluid intake logs over the course of the 36 h and 15 min sleep-deprivation 
period of this study. All research subjects were male (19 to 39 years old), were informed 
concerning all study experimental procedures, were informed concerning risks and benefits and 
were made aware of their entitlements and confidentiality rights. All research subjects read and 
signed an ICD prior to participating in any aspects of this research project. The psychological 
testing conducted during the first phase of cognitive fatigue study included the PVT and ANAM- 
core tests. During the psychological testing phase of the study, beginning 12 h after awaking, 
subjects were provided standard meals (Table 1). Descriptions of these psychological task 
classifier tests are provided in the previously published technical report for this study (Harville et 
al., 2010). Study subjects were required to record sleep/wake cycles for 3 days prior to the start 
of the study using wrist-worn actigraphs to ensure all subjects received approximately the same 
amount of sleep within the time window of 2300 to 0700 h. After two evenings of training, study 
participants were exposed to 36 hours-15 minutes of sustained wakefulness, during which, urine 
samples were collected at various time-points. During the last 24 hours-15 minutes, operational 
work was simulated using repeated cognitive tests (six 4 h blocks). Urine samples were collected 
cold from all subjects beginning with the first void urine following an eight hour overnight fast 
(0 h) and then at 12 h, 20 h, 28 h and 36 h. Urine samples were then immediately frozen and 
stored at -20 C prior to being shipped on dry ice to Air Force Research Laboratory (AFRL), 
Molecular Bioeffects Branch, for NMR analysis. A schematic of the experimental design and 
time-line for urine collection is shown in Figure 1. 
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Table 1: Standard 2400 calorie meal plan (male) provided during 36 h sleep deprivation 
study 
 
Friday 7pm, Dinner (750 calories) 
1 cup chicken noodle soup 
6 oz sirloin 
1 medium baked white potato 
1 cup broccoli 
3 tsp margarine 
1 fat free sour cream 
1 pkg Teddy Grahams Cinnamon 
Salt & pepper 
 
Friday 11pm, Snack (200 calories) 
1 Quaker Cereal Bar-Apple Crisp 
1 cup orange juice 
 
Saturday 3am, Snack (200 calories) 
1 Quaker Cereal Bar-Apple Crisp 
1 cup fat-free milk 
 
Saturday 7am, Breakfast (450 calories) 
1 container Wheaties cereal 
1 banana 
1 cup fat-free milk 
1 cup 100% orange juice 
3 pkgs sugar 
 
Saturday 11am, Lunch (600 calories) 
2 slices whole-wheat bread 
4 oz turkey lunch meat 
1 slice cheese 
2 tsp mayonnaise 
1 tsp mustard 
½ cup baby carrots 
1 apple 
 
Saturday 3pm, Snack (200 calories) 
1 Quaker Cereal Bar-Apple Crisp 
1 cup fat-free milk 
10 
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Figure 1. Cognitive fatigue study experimental design. 
 
 
3.2 Pre-Study Restrictions 
 
Participants were not allowed any naps or caffeine during the 1-hour, 30-minutes refresher 
training or during the 24-hour, 15-minutes protocol. Research subjects were instructed at the 
first of two training sessions for personal computer (PC)-based cognitive testing tasks (i.e. PVT 
and ANAM) to reduce their daily caffeine consumption 1/3 each day and to consume no caffeine 
on the study start day.  Subjects were also instructed 72 h prior to the start of the study to get a 
minimum of seven hours sleep each night.  Study participants were not allowed to take 
medications of any kind (including over-the-counter), use tobacco, or ingest alcohol from 24 h 
prior to providing their first urine sample until the end of the study. Additionally, they were told 
not to consume fish, cheese, garlic, onion, beetroot, asparagus, cherries, grapefruit, or liquorice 
over this same time period. Furthermore, subjects were instructed not to perform any strenuous 
exercise during this period of time. Strenuous exercise was defined as anything that increased 
the heart rate above 140 beats per minute. Study participants were also subjected to an overnight 
fast (8 h) prior to providing their first urine sample 12 h prior to the start of the study. 
 
 
3.3 Caloric Intake 
 
Food logs were used to record dietary intake (food and beverage) over the total 36 h sleep 
deprivation period and cognitive testing phases of the study. Following the 8 h overnight fast, 
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subjects were allowed to eat ad libitum (except those food items noted above as pre-study 
restricted) for breakfast (~ 0700 h) and lunch (~1130 h), and recorded their food intake prior to 
the start of the study PC-based cognitive testing phase at 1900 h. Identical standard meals of 
2400 calories/day (dinner at 1900 h, breakfast at 0700 h, and lunch at 1100 h) were provided 
during the 24 h and 15 minute repeated cognitive testing phase of the study for all subjects 
beginning at 1900 on the day of testing (Table 1). Subjects also recorded their standard meal 
food intake during this phase of the study. There was free access to permitted fluids throughout 
the 24 h PC-based cognitive testing phase. Nutritional information of ad libitum diets of subjects 
was derived using a web-based nutritional database called Nutrition Data 
(www.NutritionData.com) developed by Nutrition Data. The information in Nutrition Data's 
database is derived from the United States Department of Agriculture's “National Nutrient  
Database for Standard Reference” and is supplemented by listings provided by restaurants and 
food manufacturers. The Nutrition Data analysis of type and amount of food ingested was 
conducted by a registered dietitian at Wright-Patterson Air Force Base, Dayton (WPAFB), OH 
and yielded nutritional information regarding levels of calories, carbohydrates, protein and fat 
ingested. Food logs were provided to the dietitian without any personal identifiers or information 
on cognitive performance testing outcomes. Nutritional analysis was not performed on standard 
meals because all subjects ingested the complete standard meals. Statistical analysis of 
macronutrient amounts was performed using a two-tailed Student’s t-test (p 0.05). 
 
 
3.4 Urine Sample Collection 
 
Subjects were given instructions, a cooler, ice packs, and supplies for their first urine sample 
during training. Urine was collected in a chilled graduated container. A total of five urine 
samples were collected over the course of the 36 h sleep-deprivation study.  Subjects provided a 
urine sample as soon as they woke at the start of the 36 h sleep-deprivation period and prior to 
the start of the 24 h psychological testing phase of the study at 0700 h and 1900 h, respectively. 
The remaining three urine samples were collected on the second day of the study over the 24 h 
PC-based psychological testing phase during the 1 hour study breaks at 8 hour intervals (0300 h, 
1100 h, and 1900 h). The volume of the spot urine sample was recorded and then a 20-30 mL 
portion was transferred to a plastic tube on ice prior to freezing and storage at -20 °C according 
to the provided instruction. All urine collections occurred prior to ingestion of any food or fluids. 
Furthermore, volunteers were asked to keep a detailed food log on day-1 from 0700 h to 1900 h 
and during their scheduled 1 hour breaks throughout the 24-hours and 15-minutes psychological 
testing period. The urine samples were then transported from Brooks City Base, TX to WPAFB 
on dry-ice in an insulated pack. Upon arrival at WPAFB, all urine samples were thawed at 4 °C 
and then centrifuged at 2500 x g for 10 min at 4 °C to remove any solid debris from the urine. 
Portions (1.0 mL) of the supernatant fluid were then stored at -80 °C prior to analysis using 
NMR spectroscopy. 
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3.5 Urine Sample Preparation 
 
Urine samples for NMR analyses were prepared as described by Robertson et al. (2000) and 
modified as follows.  Frozen (-80 °C) urine samples were thawed at 4 °C overnight, and then 
equilibrated to room temperature just prior to NMR sample preparation. A 600 µL aliquot of 
urine was transferred to a 1.5 mL Eppendorf tube, mixed with 300 L of phosphate buffer (0.2 
M monosodium phosphate and 0.2 M disodium phosphate, pH 7.4), and allowed to equilibrate 
for ten minutes. Samples were then centrifuged at 5000 rpm for ten minutes to remove any 
particulate matter, and a 550 µL aliquot of supernatant was transferred to a 5 mm NMR tube. An 
internal standard consisting of 150 µL of trimethylsilylpropionic (2, 2, 3, 3 d4) acid (TSP) 
dissolved in deuterium oxide was then added at a final concentration of 2 mM. Study urine 
samples were stored at -80 °C until all samples had been satisfactorily analyzed by NMR and all 
data collection results had been validated. Urine samples were then placed in biohazards bags 
and disposed of as biohazardous waste. 
 
 
 
3.6 NMR Data Acquisition and Processing 
 
Proton NMR spectra were acquired at 25 °C on a Varian INOVA NMR instrument operating at 
600 MHz. Water suppression was achieved using the first increment of a Nuclear Overhauser 
Effect Spectroscopy (NOESY) pulse sequence, which incorporates saturating irradiation (on 
resonance for water) during the relaxation delay (7.0 s total; 2 s with water pre-saturation) and 
the mixing time (50 ms total; 42 ms with water irradiation). Data was signal averaged over 128 
transients using a 4.0 s acquisition time and interpulse delay of 11.05 s. 
 
NMR spectral data were processed using Varian software (VNMR 6.1c) and employing 
exponential multiplication (0.3 Hz line-broadening), Fourier transformation, and baseline 
flattening (fifth-order polynomial and spline fitting routines). Spectra were then baseline 
corrected (flattened) in MATLAB (The Mathworks, Inc. Natick, MA; v. R2010b) using the 
Whittaker Smoother algorithm (with lambda value of 200) on selected spectral noise regions 
(Eilers 2003; Whittaker 1923). Spectral resonances in urine from TSP (0.0 ppm), residual water 
(4.72-5.00 ppm) and urea (5.54-6.01 ppm) were excluded from the analyses. Spectra were then 
preprocessed using a probabilistic quotient normalization (PQN) method.  This method is based 
on the calculation of a most probable dilution factor by looking at the distribution of the 
quotients of the amplitudes of a test spectrum by those of a reference spectrum (Dieterle et al., 
2006). To reduce the dimensionality and mitigate peak misalignment, a dynamic programming- 
based adaptive binning technique was employed (Anderson et al. 2011) using a minimum and 
maximum distance between peaks in a single bin of 0.001 and 0.04 ppm, respectively. Bin 
boundaries were then manually adjusted to further mitigate peak misalignment, and to keep 
known J-coupled multiplets within that same bin (e.g., doublets, triplets, etc). Integrated bin 
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2 
n    
2 
areas were transferred to an Excel file and normalized to the TSP signal intensity.  Data were 
then autoscaled using various datasets as reference. 
 
 
 
3.7 NMR Data Acquisition and Processing 
 
Multivariate data analyses were conducted on binned, scaled spectral data using MATLAB 
software. Binned NMR data were scaled to a chosen reference dataset by subtracting each bin 
value from the mean value for the corresponding bin in the reference data, then dividing this 
value by the standard deviation of the reference data (auto-scaling). 
 
Principal Component Analysis (PCA) provided a first-approach, unsupervised technique, for data 
visualization. As previously described (Mahle et al. 2010), PCA model constructs were based on 
specific experimental groups to explore any systematic differences between groups that may 
exist. Once the model is constructed, other groups can then be superimposed into the 
visualization, by applying the model-specific bin coefficients (PCA loadings), to show how they 
compare. Thus PCA models were constructed to maximize visualization of specific responses 
based upon the nature of the effects being assessed, and PCA scores plots were used to help 
identify the time points of maximum effects for treatments. 
 
Orthogonal Projection onto Latent Structures - Discriminant Analysis (OPLS-DA) was used as a 
supervised technique to classify data and identify salient features that allow class separation 
(Wold et al. 2001). In order to apply OPLS-DA, spectral data were collected into a matrix of 
variables or bins (X) and a vector of categorical labels (Y), representing the effects.  These data 
were then analyzed and modeled as follows: (1) determine a specific time point of interest; (2) 
encode each treatment and corresponding control group as a two-group problem and analyze 
with OPLS; (3) using the model created for this specific two-group problem, project the 
remaining samples from other groups into the OPLS model. Therefore, OPLS enabled 
classification into specific groups. The OPLS model was evaluated on its predictive ability, using 
the Q
2 
(coefficient of prediction) metric. Q
2 
was calculated as follows: 
 
 
 
PRESS 
n 
ei 
n 
yi  ŷi 
Q
2  
1 SSY 1
i1 
n  
  
1 i1 
2 2 
( yi  yi ) 
i1 
yi  yi 
i1 
 
 
where PRESS is the Predicted Residual Sum of Squares calculated as the residual ei between the 
predicted and actual Y (class labels) during leave-one-out cross-validation, SSY is the Sum of 
Squares for y, ȳ is the y mean across all samples, and ŷi is the y value for i
th 
sample.  As Q
2 
approaches 1, the more predictive capability the model exhibits.  A Q
2 
value less than zero 
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indicates that the model has no predictive power. A permutation test was performed to evaluate 
the significance of the Q
2 
metric.  The test involved repeatedly permuting the data labels and re- 
running the discrimination analysis, resulting in a distribution of the Q
2 
scores (Westerhuis et al. 
2008). The Q
2 
from the correctly labeled data is then compared to the distribution to determine 
the significance of the model at a specified alpha (set herein at = 0.01). 
 
Variable selection (salient bins) from OPLS-DA was also statistically evaluated.  The bin 
loadings, commonly referred to as coefficients, were compared to calculated null distributions in 
order to select for significance.  The null distribution for each bin was determined by refitting the 
OPLS model to datasets in which each bin was independently and randomly permuted to remove 
any correlation between it and the control/treatment groups.  The true OPLS model loading was 
then compared to the resulting null distribution of loadings, and values in the tail (greater than 
99.5% or less than 0.5% of the null distribution; corresponding to = 0.01) were assumed to 
contribute significantly to the model.  The permutation was initially repeated 500 times for each 
bin and those near-significant loadings (greater than 92.5% or less than 7.5% of the null 
distribution; corresponding to = 0.15) were selected for 500 additional permutations (total 
1000). Comparisons between individuals were used to help identify metabolite profiles or 
markers of fatigue susceptibility. The salient spectral resonances were assigned to metabolites 
using Chenomx 5.1 software, on-line NMR databases (i.e., mmcd.nmrfam.wisc.edu; U Wisc, 
etc), and by "spiking" samples with known compounds, if necessary. 
 
 
4.1 RESULTS 
 
4.2 Pre-Study Caloric Intake 
 
Following an overnight fast (7 h), study subjects were allowed to consume breakfast and lunch 
food items of their choosing, except those identified as dietary restricted in the ICD document, 
and the amount and type of food eaten was recorded. All subjects ate breakfast at approximately 
0630 h and lunch at approximately 1130 h. No additional food-intake occurred over the next 7 h 
until the start of the cognitive testing phase of the study at 1700 h. Following the study, food logs 
were sent to an Air Force dietitian, Wright-Patterson AFB, OH without any personal identifiers 
or cognitive performance rankings. Food logs were analyzed using Nutrition Data. Pre-study 
caloric intake determinations indicated that study subjects that were identified as more resistant 
to the effects of sleep deprivation-induced fatigue had an average higher caloric intake (1590 
calories) when compared to those subjects classified as sensitive to sleep deprivation-induced 
fatigue (1087 calories; Figure 2A). Furthermore, those subjects classified as sensitive to the 
effects of sleep deprivation-induced fatigue derived a higher percentage of their total caloric 
intake from carbohydrates, and demonstrated a lower percentage of their total caloric intake from 
protein and fat, when compared to the fatigue resistant group (Figure 2B).  Due to the higher 
caloric intake of the fatigue resistant group, these subjects did demonstrate higher levels of 
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Figure 2 Average caloric intake for subjects classified via psychological testing as fatigue- 
resistant (n = 6) and fatigue-sensitive (n = 6). Bars represent mean + SD. Fatigue-resistant 
subjects generally derived a higher percentage of their dietary intake from protein, while fatigue- 
sensitive subjects derived a higher percentage of their dietary intake from carbohydrates. Caloric 
intake and macronutrient distribution determined from subject food logs 12 h prior to 
psychological testing using Nutrition Data analysis. 
 
 
carbohydrate, fat and protein intake than the fatigue sensitive group. However, only the amount 
of protein ingested was found to be significant (2-fold higher) when compared to the fatigue 
sensitive group (Figure 3). 
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Figure 3. Quantitation of macronutrients ingested by fatigue-resistant (n = 6) and fatigue- 
sensitive (n = 6) subjects 12 h prior to cognitive testing using Nutrition Data analysis. Bars 
represent mean + SD. Although fatigue-resistant subjects ingested higher amounts of 
macronutrients, only protein amounts were found to be significant. (
* 
p ≤ 0.05) 
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4.3 Psychological Testing 
 
Psychological testing consisting of the PVT and ANAM-core tests were performed in six 4 h 
blocks over 24 h and the results were reported in the technical report by Harville et al. (2010). 
The findings reported in this technical report indicated that the PVT and the ANAM-math tests 
were the primary and secondary classifiers for cognitive fatigue susceptibility, respectively 
(Figure 4). Psychological testing results from all cognitive tests given indicated that two subsets 
of subjects were identified from the median subject fatigue classification split (i.e. 11 resistant 
and 12 sensitive). One of the cohort subsets (n = 6) was consistently classified as “resistant” to 
the effects of sleep deprivation-induced fatigue (i.e. scored high in all test modules given). The 
other cohort subset (n = 6) was consistently classified as “sensitive” to the effects of sleep 
deprivation-induced fatigue (i.e. scored low in all test modules given). The remaining 11 subjects 
demonstrated mixed results on all psychological testing, scoring highly on one test and poorly on 
another, and were classified as variable to the effects of fatigue. 
 
4.4 NMR Spectroscopy of Human Urine 
The representative NMR spectra of human urine shown in Figure 5 show the changes in 
endogenous components of urinary metabolites observed at 0 h hours (12 h prior to start of 
psychological testing) and at 28 h of sleep deprivation between two subset populations (n = 
6/group) of the cohort that were identified as being sensitive (Figure 5A) or resistant (Figure 5B) 
to sleep deprivation-induced fatigue. The NMR instrument phasing and baseline correction of the 
data was not used to generate the spectra in Figure 5. Instead, the automatic data processing 
procedure of the Chenomx (Chenomx Inc., Edmonton, Canada) NMR Processor application was 
implemented. In order to visualize the data, the NMR traces were binned with bin sizes of 0.0005 
ppm (i.e. full resolution), and the data were scaled using the area of the peak associated with the 
internal standard (i.e. TSP). Water and urea resonances were removed from the NMR traces. 
Visual inspection of the spectral resonance intensity peaks from a number of metabolites clearly 
shows that they have been altered when compared either between group classification (i.e. 
resistant vs. sensitive), or time (i.e. 0 h vs. 28 h). Psychological testing involving PVT and 
ANAM testing indicated that 28 h of sleep deprivation resulted in peak fatigue in all subjects 
(Harville et al., 2010) and correlated with changes observed in urinary metabolite profiles 
between the two extreme cohort groups at that time. 
 
 
4.5 Unsupervised Principal Component Analysis (PCA) of NMR Data 
Unsupervised PCA analysis assumes no knowledge a priori and is the predominant linear 
dimensionality reduction technique applied to a wide variety of scientific datasets. PCA attempts 
to map data points from a high dimensional space to a low dimensional space while keeping all 
relevant linear structure intact. The only input parameters are the coordinates of the data points 
and the number of dimensions that will be retained in the mapping. The NMR spectral intensities 
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Figure 4. Plots of the primary (PVT) and secondary (ANAM-Math) psychological 
classifiers for fatigue susceptibility reported by Harville et al. (2010) for fatigue resistant 
and fatigue susceptible subjects for average training (T) and testing trials (1-12). Testing 
trials were performed two times within six 4 h time-blocks over a 24 h period as indicated in 
Figure 1. 
 
 
 
from each dynamically adaptively binned urine spectrum provided multivariate data input to 
PCA.  The model parameters used to generate PCA scores plots (PC1 vs. PC2; representing 33% 
data variance) for the three classification groups (resistant, sensitive and variable) were based on 
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Figure 5. Representative 600 MHz NMR spectrum of urine from a fatigue-sensitive (A) and 
fatigue-resistant (B) subject 12 h prior to cognitive testing (0 h) and after 28 h of sleep 
deprivation. 
 
 
NMR spectra from all 23 subjects at 0 h and 28 h sleep deprivation time points; maximal 
differences in cognitive performance were noted between these two time points via 
psychological testing in a previous study (Harville et al., 2010). Although all time points from all 
subjects were included in the data analysis, only data for the 0 h and 28 h sleep deprivation time 
points were plotted for clarity (Figure 6). ). It should be noted that ideal model parameters for the 
analysis work best when differences exist between time points or treatment groups. PCA 
parameter models generated using similar NMR spectral profiles between time points or 
treatment groups will not result in distinguishing treatment group classification (i.e. no treatment 
effect). The data shown in Figure 6 indicate the centric mean ± 2SEM (or 95 % confidence 
interval [CI]) for the various fatigue classification groups at 0 and 28 h of sleep deprivation. 
Differences in mapping position reflect changes in biochemical composition of the urine. This 
scores plot clearly shows separation between the 95% CIs at 0 h and 28 h for each of the fatigue 
classification groups. Furthermore, the 95% CIs do not overlap in space between the fatigue 
resistant and fatigue sensitive subjects at both 0 h and 28 h. Interestingly, the fatigue variable 
20 
PENDING Distribution A: Approved for public release; distribution unlimited (approval given by local Public Affairs Office #88ABW-2013-XXXX) 
 
 
 
subjects’ 95% CI at 28 h was located in space between that of the fatigue resistant and fatigue 
sensitive groups 95% CIs (Figure 6). The 95% CIs for the fatigue variable group was found to 
overlap both the fatigue resistant and fatigue sensitive group 95 % CIs at both 0 and 28 h of sleep 
deprivation (Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. PCA scores plot (PC1 vs. PC2) of all study subjects as a function of sleep 
deprivation time. Fatigue resistant (n =6; circles), fatigue sensitive (n =6; squares) and fatigue 
variable (n = 11; triangles) data are plotted at 0 h (open symbols) and 28 h (filled symbols) of 
sleep deprivation as the centroid mean value for the first two principal components (PC1 vs. 
PC2) ± 2SEM (95% CI) in two dimensions (ellipse). PCA model was generated from urine NMR 
spectra from all subjects at 0 h (12 h prior to cognitive testing) and 28 h of sleep deprivation. 
Other time points were included in the analysis, but were omitted from this plot. 
 
 
A PCA scores plot (PC1 vs. PC2; representing 47 % data variance) was then generated from the 
subject urinary metabolite profiles using the same model parameters as described above, but 
derived from only the fatigue-resistant and fatigue-sensitive classification groups at all time 
points.  Although the 95% CIs derived from the subjects of these two fatigue classification 
groups clearly shows separation between classification group (resistant vs. sensitive) at 0 h (12 h 
prior to the start of cognitive testing) and 28 h of sleep deprivation (Figure 7), the CIs were 
larger than that observed in Figure 6. The larger CIs observed when PCAs were performed using 
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only two classification groups (fatigue resistant and fatigue sensitive) were due to the greater 
variability (or SE) resulting from the decrease in “N” value from 23 to 12. 
 
 
 
 
 
 
Figure 7. PCA scores plot (PC1 vs. PC2) of fatigue-resistant and fatigue-sensitive subjects 
as a function of sleep deprivation time. Fatigue resistant (n =6; circles) and  fatigue-sensitive 
(n =6; squares) data are plotted at 0 h (open symbols) and 28 h (filled symbols) of sleep 
deprivation as the mean value for the first two principal components (PC1 vs. PC2) ± 2SEM 
(95% CI) in two dimensions (ellipse). PCA model was generated from urine NMR spectra as 
described in Figure 6 legend. Other time points were included in the analysis, but omitted from 
this plot. 
 
 
A PCA scores plot (PC1 vs. PC2) using the same model parameters as above and plotted over 
time, indicated that maximal group separation, based on urine analysis, occurred at 28 h of sleep 
deprivation (Figure 8). The urine collected at this time was 4 h following the maximal fatigue 
impact as determined by PVT and ANAM psychological testing performance reported in the 
previous technical report (Harville et al., 2010). This PCA plot also indicated that at 36 h of sleep 
deprivation the urinary metabolite profiles between the two fatigue classification groups 
appeared to be returning to that observed at the beginning of the study (Figure 8). This result also 
correlated with psychological testing results reported in the previous technical report that 
described improved performance related to what was termed a “going home” effect (Harville et 
al., 2010). 
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Figure 8. PCA plot of fatigue-resistant and fatigue-sensitive subjects over 36 h of sleep 
deprivation. Fatigue resistant (n =6; filled symbols) and fatigue-sensitive (n =6; open symbols) 
data are plotted at 0 h (circle), 20 h (triangle), 28 h (square) and 36 h (diamond) of sleep 
deprivation as the mean value for the first two principal components (PC1 vs. PC2) ± 2SE (95% 
CI) in two dimensions (ellipse). The 12 h sleep deprivation time point data overlapped with the 0 
h data and is not shown for purposes of clarity. 
 
 
4.6 Supervised Orthogonal Projection onto Latent Structures (OPLS) Discriminant 
Analysis of NMR Data 
Supervised discriminant analysis is a statistical technique to classify objects into mutually 
exclusive and exhaustive groups based on a set of measurable object's features. The purpose of 
OPLS-DA is to classify objects (people, things, etc.) into one of two or more groups based on a 
set of features that describe the objects (e.g. gender, age, fatigue state, diet, etc.). Therefore, 
supervised analysis attempts to reduce variability within a classification group while maximizing 
separation between classification groups. An OPLS-DA was conducted modeling NMR spectra 
from Resistant (all times) + Sensitive (all times) subjects. Results from this analysis (Q
2 
= 0.68; 
threshold = -0.044; leave-one-out predictive accuracy = 97%) indicated that these data are 
significant at p < 0.01.  The T-score scatter plot of study subjects clearly indicated that fatigue- 
resistant and fatigue-sensitive subjects clustered together and were separated from each other in 
graphical space at both 0 h and 28 h (Figure 9). Furthermore, within-group fatigue classification 
separation was also noted between 0 h and 28 h. It was also observed that clustering of subjects 
in both fatigue-resistant and fatigue-sensitive groups at 0 h was less variable than at 28 h; 
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Figure 9. T-scores scatter plot derived from an OPLS-DA of fatigue-resistant (n = 6; circle) 
and fatigue-sensitive (n = 6; square) data modeled by fatigue classification group at 0 h 
(open symbols) and 28 h (filled symbols). Fatigue resistant and fatigued-sensitive group 
subjects are observed to cluster together and be separated by group classification (dashed line) 
and time point (solid line). 
 
 
 
presumably, due to autoscaling the NMR data to this time point. However, it is also possible that 
overnight fasting prior to sample collection contributed to this observation. Variability in urinary 
metabolite profiles was observed to be greatest in the fatigue-sensitive group at 28 h when 
compared to the fatigue-resistant group at this time (Figure 9). When the subject clusters were 
plotted as the centric mean ± 2SEM (95% CI), clear separation between fatigue classification 
groups and time was clearly evident (Figure 10). 
24 
PENDING Distribution A: Approved for public release; distribution unlimited (approval given by local Public Affairs Office #88ABW-2013-XXXX) 
 
 
 
 
Figure 10. T-scores plot showing 95% CI derived from OPLS-DA of fatigue-resistant (n 
= 6; circle) and fatigue-sensitive (n = 6; square) data modeled by fatigue classification 
group at 0 h (open symbols) and 28 h (filled symbols). Data are plotted as the centric mean 
± 2SEM (95% CI ellipse). OPLS-DA was performed using a -1 cross validation, an alpha of 
0.01 and 500 permutation runs. Significant differences between fatigue classification groups 
was indicated with a Q
2 
value of 0.685, threshold value of -0.03 and accuracy value of 97%. 
OPLS-DA identified 23 significant NMR spectral peaks that were responsible for 
classification group separation. 
 
Using the significant variables, or spectral features, derived from this OPLS analysis that were 
responsible for the fatigue classification separation, 43 significant bins (spectral features) were 
identified that were found to be associated with 23 independent metabolite signals (Table 2). Of 
these 23 signals, we were able to identify 16 metabolites using the Chenomx commercial 
software database; 7 signals are unidentified as of yet (Table 2). Statistical analysis (t-test and 
Bonferroni multiple testing) indicated that 14 of the 23 metabolites were significantly altered 
when fatigue-resistant and fatigue-sensitive groups were compared; five of these metabolites 
could not be identified. 
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Table 2. List of 23 urinary metabolites determined to be significant by OPLS-DA modeling 
Resistant (all times) versus Sensitive (all times). NMR spectral data were normalized using 
Probabilistic Quotient Normalization (PQN).  Data represent the Mean ± SEM relative signal 
intensity values. Statistical analyses tested whether the means were different between Resistant 
vs. Sensitive groups. Statistically significant metabolites are highlighted. 
 
All times combined 
Mean ± SEM (X 10-4); N = 30 
Metabolite PPM Resistant Sensitive 
Methylmalonic acid 1.23 12.18 ± 0.77 13.15 ± 0.61 
2,2-Dimethylsuccinate 1.28 4.76 ± 0.27 ** 8.13 ± 1.04 
Alanine 1.49 7.73 ± 0.50 * 9.77 ± 0.59 
3-Hydroxyisovalerate 2.35 14.99 ± 1.61 * 11.06 ± 1.11 
Pyruvate 2.37 2.11 ± 0.12 2.78 ± 0.34 
Alpha-ketoglutarate 2.45 8.70 ± 0.43 10.14 ± 0.62 
Trimethylamine 2.88 2.24 ± 0.17 * 3.09 ± 0.27 
Tyramine 2.91 6.19 ± 0.32 ‡ 7.84 ± 0.33 
Creatinine 3.05 412.34 ± 13.33 411.41 ± 18.43 
Phosphorylcholine 3.23 19.57 ± 2.61 23.27 ± 2.35 
Betaine 3.27 12.97 ± 1.24 17.10 ± 1.91 
Taurine 3.43 17.01 ± 1.69 ‡ 26.97 ± 2.27 
N-methylnicotinate 4.48 1.48 ± 0.14 * 2.29 ± 0.28 
Homovanillate 6.99 2.54 ± 0.28 * 1.81 ± 0.18 
Tyrosine 7.21 12.01 ± 1.26 ** 7.75 ± 0.85 
Hippurate 7.84 21.03 ± 2.31 18.32 ± 1.43 
Unidentified # 1 1.128 0.80 ± 0.05 ‡ 0.54 ± 0.03 
Unidentified # 2 2.15 3.52 ± 0.34 4.43 ± 0.43 
Unidentified # 3 2.86 0.70 ± 0.08 * 1.06 ± 0.11 
Unidentified # 4 3.36 5.81 ± 0.31 ‡ 4.21 ± 0.26 
Unidentified # 5 4.14 7.30 ± 0.35 * 17.38 ± 4.16 
Unidentified # 6 7.015 0.47 ± 0.07 0.35 ± 0.04 
Unidentified # 7 7.31 1.02 ± 0.06 ‡ 0.62 ± 0.04 
 
Asterisk(s) indicates means are significantly different by t-test (*, p≤0.05; **, p≤0.01), and the 
dagger (‡) indicates means are significantly different by t-test and Bonferroni correction for 
multiple testing (p≤0.05). 
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4.6  Urinary Levels of Significant Metabolites 
Urinary levels of the statistically significant 14 metabolites highlighted in Table 2 were plotted 
over the 36 h sleep deprivation-induced fatigue study. Metabolite levels in urine were based 
upon relative signal intensities from the PQN-adjusted spectra, which accounts for differences in 
urine sample concentrations. Urinary metabolite levels at various time points over the 36 h of 
sleep deprivation indicated that tyrosine, homovalinate and 3-hydroxyisovalerate were observed 
to be at higher levels in fatigue-resistant subjects when compared to fatigue-sensitive subjects 
(Figure 11). In contrast, metabolite levels of tyramine, N-methylnicotinate, taurine, alanine, 2,2- 
dimethylsuccinate and trimethylamine were found to be elevated in fatigue-sensitive subjects 
over 36 h compared to fatigue-resistant subjects (Figure 11). Three of the five significant 
unidentified urinary metabolites with peaks at 1.128 ppm, 3.36 ppm and 7.31 ppm were found to 
be elevated in fatigue-resistant subjects over 36 h, when compared to fatigue-sensitive subjects, 
while the remaining two unidentified metabolite NMR peaks at 2.86 ppm and 4.14 ppm were 
found to be elevated in fatigue-sensitive subjects, when compared to fatigue resistant subjects 
(Figure 12). 
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Figure 11. Levels of significantly identified urinary metabolites, using Chenomx database, 
responsible for fatigue classification and monitored over 36 h of sleep deprivation using an 
interactive spectral de-convolution algorithm in MATLAB. 
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Figure 12. Levels of significant unidentified urinary metabolites responsible for fatigue 
classification, and monitored over 36 h of sleep deprivation using an interactive spectral de- 
convolution algorithm in MATLAB. 
 
 
5.0 SUMMARY AND DISCUSSION 
 
High operational tempos, sustained operations, disruptive sleeping environments and insufficient 
staffing make fatigue a growing problem in military operations. The impact of military fatigue 
on operational performance has been long known and dates back to the 1920s (Caldwell et al., 
09). Fatigue in the military affects both soldiers and aviators and is a significant safety and 
operational issue resulting in diminished alertness and performance (Kruger, 1991; Miller et al., 
2007). Pilot fatigue is well documented and is a significant problem in modern aviation 
operations, largely due to long duty periods, circadian disruptions, and insufficient sleep that can 
turn a routine operation into a potentially fatal situation (Weeks et al. 2010). With regards to the 
soldier, as a decision-maker, they interface with increasingly sophisticated technology for 
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communications, targeting, and weapons systems. Therefore, the human operator in both air and 
ground operations becomes the weakest element of these operations where sustained optimal 
performance is required. Scheduling, sleep deprivation, circadian disruptions, and extended duty 
periods continue to challenge the alertness and performance levels of both pilots and ground 
crews. At present, none of the real-time fatigue detection technologies (i.e. predictive modeling 
algorithms, EEG, biomathematical models of alertness) are adequately proven in an aviation 
environment to permit extensive utilization (Caldwell et al., 2009). 
 
Although there has been much research into sleep and sleep disorders, discovery of biomarkers 
that accurately characterize sleep deprivation, or predict sleepiness, has been difficult to realize. 
Currently, objective determinations of sleepiness, such as psychomotor vigilance and multiple 
sleep latency tests are not inclusive of all types of sleep deficiencies and are not conducive to use 
in environmental settings outside of the laboratory. Development of accurate and easy to use 
biomarkers is important because current subjective assessment of sleepiness and sleep disorders 
are not reliable. To date, there have been relatively few articles published concerning 
identification of biomarkers related to sleep deprivation or sleepiness. 
 
The current study investigated whether NMR-based metabolomics could be used to identify early 
metabolic markers of sleep deprivation-induced fatigue that was predictive of cognitive 
performance degradation. There is precedence for this approach in animal studies for predicting 
drug sensitivity using rats. Clayton et al., (2006) demonstrated that NMR analysis of rat urine 
prior to exposure to acetaminophen could predict animal sensitivity to this compound prior to 
being exposed. The urine is ideally suited for metabolomics analysis because it contains and 
concentrates essentially all endogenous and exogenous metabolites found in the body. These 
metabolites represent the end-products of countless interdependent macromolecular interactions. 
 
Therefore, the power of metabolomics is derived from the fact that these small molecules 
effectively reside at the top of the genomic pyramid. Because metabolomics measures the " end 
result” of multiple protein, gene, and environmental interactions, it is a particularly good 
i n d i c a t o r of an organism's phenotype or physiology (Wishart 07). Furthermore, it allows 
researchers the capacity to quantitate these molecular phenotypes. However, as with any 
technology, one must be aware of the limitations of the technology being applied to address a 
research hypothesis. 
 
Although NMR-based metabolomics requires minimal sample preparation, is less destructive and 
is quantitative, it is not as sensitive as other methods, such as mass spectrometry, and metabolites 
that are found in low concentration (< 0.1 mM) may not be detected. Metabolite variability, 
especially in humans, is another concern. It has been shown in rodents that species, strain, 
genetics, sex, age, hormone concentrations, diurnal cycles, diet, temperature, stress, and gut 
microflora all contribute to the metabolic composition of the urine (Dai 08). Variations in diet 
and environment are important confounding factors in human studies. However, these can be 
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controlled somewhat by monitoring food and drink intake and by restricting ingestion of specific 
foods and drugs that would compromise data analysis. In addition, collecting samples after 
fasting can also help eliminate dietary issues. This approach to reducing metabolite variability in 
human studies has been implemented and suggests that it is possible to collect consistent 
metabolomics data in clinical studies (Lentz 03). The current study utilized the same dietary and 
drug restrictions and fasting described previously by Lentz (2003). Visual inspection of 
representative NMR spectra in the present study (Figure 5) clearly indicated differences in 
metabolite profiles between subjects who were classified as fatigue-sensitive and fatigue- 
resistant via psychological testing (Figure 4; Harville et al., 2010). 
 
Cognitive testing conducted during Phase I of this study and reported by Harville et al. (2010), 
used a median split of the test scores for PVT and ANAM-core (math, grammatical reasoning 
and continuous performance) tests to classify subjects as fatigue-sensitive or fatigue-resistant. 
Findings published in this technical report indicated that PVT and ANAM-math tests were found 
to be the primary and secondary classifiers for fatigue, respectively. In the current technical 
report concerning classifying subject fatigue status based on urinary metabolite profiles, we 
further refined the subject classification groups. Use of the median split of cognitive test scores 
reported in the previous technical report of the 23 study subjects often led to variable results 
when different cognitive tests were compared. Therefore, for metabolite analysis we classified 
fatigue-resistance subjects (n = 6) as those subjects who performed well on all cognitive tests 
given (PVT and ANAM-core) and fatigue–sensitive subjects (n = 6) as those subjects who 
performed poorly on all cognitive tests given. The remaining 11 subjects were classified as 
fatigue-variable as they were found to perform well on some cognitive tests and poorly on others. 
 
Unsupervised PCA is the first step in the multivariate statistical analysis of NMR spectral data. 
This unsupervised PCA assumes no knowledge a priori and is based on the distribution of 
eigenvectors, or principal components, which best explains the variance in the NMR spectral 
data. To reduce the dimensionality of the transformed data, typically only the first 4 or 5 
principal components are used and these should capture a high percentage of the variance in the 
data if distinct patterns exist. PCA of urinary NMR spectra from fatigue-resistant, fatigue- 
sensitive and fatigue-variable subjects indicated that the urinary profiles for fatigue-resistant and 
fatigue-sensitive subjects were distinctive, exhibiting group separation occurring at both 0 h and 
28 h (Figure 6). Indeed, these analyses showed that 50-58 % of the data variance is captured in 
the first 4 PCs. It is important to note that the 0 h time point is actually the baseline urine sample 
obtained after an overnight fast and is 12 h prior to the 24 h cognitive testing portion of the study 
(see Figure 1). Therefore, the reported time points in all figures reflect subject awake-time. The 
fatigue-variable group demonstrated urinary metabolite profiles that were similar to the other two 
classification groups at 0 h and was found to be intermittent between the other two fatigue 
classification groups at 28 h. Interestingly, this separation was distinct from the fatigue-sensitive 
group and more similar to the fatigue-resistant group (Figure 6). 
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When PCA was performed using only the fatigue-resistant and fatigue-sensitive subjects, 
separation between these two groups is observed at both 0 h and 28 h of sleep deprivation 
(Figure 7). However, compared to Figure 6 where all 23 subjects were included in the analysis, 
the separation, although still significant, between the fatigue-resistant and fatigue-sensitive 
subjects at 28 h was not found to be as great; PCA correlation appeared to be greater when the 
model was built on the fatigue resistant and fatigue sensitive groups only (i.e. % variance 
captured in first 4 PCs was greater) compared to the 3-group analysis. Furthermore, the 
variability within the fatigue-sensitive group was also found to be greater than that observed in 
Figure 6. This was more likely due to the reduced “N” value from 23 to 12 subjects in the PCA 
resulting in a greater SE. When all time points were superimposed onto the scores plot from the 
analysis involving only the fatigue-resistant and fatigue-sensitive subjects, changes in urinary 
metabolite profiles can be observed over time (Figure 8). The 12 h time point is not shown in this 
Figure for clarity because it clustered with the 0 h baseline samples. An interesting observation 
here was that after 36 h of being awake, the urinary profiles between the fatigue-resistant and 
fatigue sensitive subjects were becoming more similar and were moving back towards their 0-12 
h profiles. 
 
Harville et al. (2010) noted that cognitive test scores improved towards the end of their 
physiological study (36 h time point) and hypothesized this improvement to have been the result 
of a psychological phenomenon called “the going home effect”; subjects’ cognitive performance 
increases because of the realization that they would be returning home soon. Interestingly, the 
amounts of tryrosine, HV, and 3HI, all of which were elevated in the urine of the fatigue- 
resistant subjects, appeared to become similar in concentration between the two fatigue 
classification groups at the end of the 36 h sleep-deprivation study (Figure 11). This also was 
found to be associated with the so called “going home” effect reported in the previous technical 
report (Harville et al., 2010) to account for improved cognitive performance by all subjects 
during the last testing session of the study. In contrast, with the exception of tyramine, the 
significant metabolites elevated in the urine of the fatigue-sensitive subjects appeared to remain 
elevated throughout the 36 h sleep-deprivation period of the study. The levels of urinary 
tyramine in the fatigue-sensitive group becoming more like that observed in the urine of the 
fatigue-resistant group towards the end of the study may be the result of increased protein intake 
(i.e. tyrosine metabolism) in this group because all subjects were on a standard diet at the onset 
of the 24 h period of sleep-deprived cognitive testing. Previous work has shown that as little as a 
4% increase in protein to a high carbohydrate diet can abolish the effects of tryptophan (induces 
sleepiness) and improve cognitive performance (Dye et al., 2000). 
 
Once it was shown that PCA of human urine from study subjects demonstrated group separation 
with regards to fatigue classification, a supervised analysis (OPLS-DA) was conducted to 
determine which metabolites were responsible for this observed separation in PCA scores plot. In 
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an OPLS-DA, knowledge is imparted to the data sets (i.e. fatigue classification, time, etc.). The 
objectives of an OPLS-DA are to maximize the separation between groups, while minimizing the 
variation within groups, and to identify the salient spectral features (or metabolites) responsible 
for group differences. When OPLS-DA was performed using NMR data obtained from the 
fatigue-resistant and fatigue-sensitive groups (n = 6/group), a scatter plot of all subjects involved 
in the analysis show a clear separation between fatigue-group classification and time (Figure 9). 
As observed with PCA, the OPLS-DA scatter plot shows that the fatigue-sensitive group 
demonstrated the greatest variability between subjects. When the data were plotted as the mean ± 
2 SE (95% CI; Figure 10), maximal separation between groups and reduced variability within 
groups is clearly evident when compared to similar PCA scores plots between these two groups 
(Figure 7). 
 
In generating the figures for OPLS-DA, NMR spectral peaks are identified that were significant 
and responsible for group separation. These spectral peaks can then be identified using 
commercial software database such as Chenomx. OPLS-DA identified 23 significant spectral 
peaks that were responsible for classifying study subjects as resistant or sensitive to sleep 
deprivation-induced fatigue, and 16 of these peaks were assigned to specific metabolites 
identified (Table 2). Although Chenomx is a leading database for identifying metabolites from 
NMR data, it is not complete. It is noteworthy that three of the significant unidentified 
metabolites that were elevated in the urine of the fatigue-resistant group (i.e. 1.128 ppm, 3.36 
ppm and 7.31 ppm) demonstrated a similar concentration pattern as that observed for the three 
significantly identified urinary metabolites (i.e. tyrosine, HV and 3HI) of fatigue-resistant group 
over time (Figure 12). The remaining two unidentified significant metabolites (i.e. 2.86 ppm and 
4.14 ppm), as that observed in the fatigue-sensitive group, remained elevated in the urine over 
the 36 h period of sleep deprivation. Although 7 of the 23 metabolite spectral peaks could not be 
identified, it may be possible to identify them using 2D NMR in the future (e.g. TOCSY, 
HMQC). 
 
Statistical analysis of the 23 significant spectral peaks identified by OPLS-DA that were 
responsible for fatigue group classification indicated that 14 were statistically significant. Nine 
of these spectral peaks could be identified using Chenomx, while 5 could not (Table 2; 
highlighted metabolites). A number of the identified urinary metabolites in both the fatigue- 
resistant and fatigue-sensitive subjects were of particular interest. Taken together, our data 
showed that measured biomolecular endpoints (urinary metabolite profiles) correlated with 
psychological endpoints (PVT and ANAM) for determining cognitive performance outcome. 
This was observed not only at the 36 h time point, but also at the 28 h time point where 
psychological testing indicated peak fatigue occurring between 24-28 h of sleep deprivation in 
all groups (Harville et al., 2010). 
 
 
5.1 Fatigue Resistant 
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With regards to the fatigue-resistant group, 6 of the statistically significant urinary metabolite 
levels were found to be higher when compared to the fatigue–sensitive group. However, only 3 
metabolites could be identified using the ChenoMx metabolomics database and these were: 3- 
hydroxyisovalerate (3-HI), tyrosine and homovanillate (HV). Increased levels of these three 
metabolites in urine are suggestive of greater protein metabolism in the fatigue-resistant group. 
Tyrosine is of particular interest because it is the precursor to three neurotransmitters: dopamine, 
norepinephrine and epinephrine (see Figure 13). 
 
Although tyrosine can be synthesized from phenylalanine in humans, it is generally derived from 
the diet where it is found in high quantities in protein-rich foods. The role of tyrosine in 
countering the effects of fatigue are well known and suggests that supplemental administration of 
tyrosine increases brain catecholaminergic neurotransmission and has beneficial effects on 
various behavioral parameter, associated with resistance to stress (Lieberman 1994 and 1999). 
Other human studies have shown that tyrosine has a positive effect on cognitive performance 
during exposure to various stresses such as temperature and altitude (Banderet and Lieberman, 
1989; Shurtleff et al., 1994). Tyrosine has also been shown to enhance performance in 
individuals exposed to psychological stress (Deijen and Orlebeke, 1994). These findings in 
humans are similar to those observed in animals showing improved cognition when under stress. 
 
As indicated above, the dopaminergic pathway has been associated with a more wakeful state. 
Dopamine synthesis in dopaminergic neurons begins with tyrosine where it is obtained from the 
circulation. Tyrosine, like other large neutral amino acids (i.e. tryptophan, phenylalanine, 
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Figure 13. Schematic pathways for synthesis of dopamine, noradrenaline, adrenaline, and 
serotonin. 5-HTP, 5-Hydroxytryptophan; PNMT, phenylethanolamine-N-methyl transferase; 
MAO, monoamine oxidase; COMT, catechol-O-methyl transferase. (Modiefied from Rubí and 
Maechler, 2010). Ovals indicate metabolites found to be significantly elevated in the urine of the 
fatigue-resistant group by NMR. 
 
 
 
leucine, histidine, etc.), cannot cross the BBB and must be actively transported across. Once 
tyrosine crosses the BBB, it is taken up and concentrated in catecholamine neurons. Once inside 
the cell, tyrosine is converted to dopamine via dihydroxyphenylalanine (DOPA). Dopamine can 
then be used as a substrate to generate norepinephrine and epinephrine or be metabolized to HV. 
 
In the kidneys, more than 95% of amino acids are filtered from the plasma and reabsorbed by the 
proximal tubules and returned back into circulation (Parvy et al., 1988). Therefore, urinary levels 
of amino acids are typically low. However, in the present study we observed significantly higher 
levels of tyrosine in the urine of the fatigue-resistant group by NMR analysis than that observed 
in the urine derived from the fatigue-sensitive group. We believe that this finding was due to 
greater dietary intake of protein in the fatigue-resistant group than that in the fatigue-sensitive 
group. This is supported by a blind dietary analysis of subject food logs using the Nutrition Data 
database that indicated a significant 2-fold greater protein intake by the fatigue-resistant subjects 
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~ 8 h prior to the 24 h of cognitive testing (Figure 3). Furthermore, a number of previous studies 
have shown increases in tyrosine, as well as other amino acids, in urine following ingestion of 
protein-rich foods (Brand et al., 1997; Parvy et al., 1988; Steele et al., 1950). This is believed to 
occur when the kidney tubular load for amino acids exceeds the rate of reabsorption and urinary 
excretion of amino acids increases proportionally (Odle et al., 1992). 
 
Homovanillate was another metabolite found to be elevated in the urine of fatigue-resistant 
subjects when compared to fatigue-sensitive subjects. A review article by Amin et al. (1992) 
indicated that dopamine is predominantly metabolized to HV and mostly excreted in a free 
unconjugated form. The unconjugated HV produced in the brain moves directly into the blood 
via active transport (organic anion transporter) across the BBB. This review also indicated that 
animal and human studies have shown that a portion of urinary measured HV originated from the 
brain. Therefore, it is possible that HV may provide an index of central dopamine neuronal 
activity. Our finding of elevated HV in the urine of the fatigue-resistant group lends further 
support of increased protein consumption leading to increased tyrosine levels and enhancement 
of the dopaminergic pathway in the brain. Elevated levels of 3-HI in the urine adds additional 
evidence that increased protein consumption in the fatigue-resistant group contributed to 
enhanced cognitive performance. This metabolite can be formed enzymatically utilizing acetyl 
CoA and is a catabolic intermediate of leucine associated mitochondrial metabolism. Increased 
dietary protein intake by the fatigue-resistant group would have increased the availability of 
leucine for mitochondrial metabolism to form 3-HI. Three other metabolites were also found to 
be elevated in the urine of the fatigue-resistant group, but they could not be identified using the 
Chenomx database. Future analysis by 2D NMR will shed some light as to the identity of these 
metabolites. Taken together, our data suggest that the higher levels of protein ingested by the 
fatigue-resistant group, when compared to the fatigue-sensitive group, ultimately lead to 
enhanced cognitive performance via stimulation of the dopaminergic pathway (Figure 13) as 
evidenced by higher levels of tyrosine, HV and 3-HI measured in the urine by NMR. 
 
 
5.2 Fatigue Sensitive 
 
In contrast to the urine profiles of the fatigue-resistant group, a number of urinary metabolites 
were identified in the fatigue-sensitive group that could be associated with a more sleepiness, or 
more fatigued, state. Eight metabolites in the urine of the fatigue-sensitive group were found to 
be significantly elevated when compared to the fatigue-resistant group. Of these eight 
metabolites, only six could be positively identified using the Chenomx database and these were: 
alanine, 2,2-dimethylsuccinate, trimethylamine (TMA), tyramine, taurine and N- 
methylnicotinate (NMN; Table 2). Two additional metabolites were observed to be significantly 
elevated, but could not be identified using Chenomx database. In addition, blind dietary analysis 
using the Nutrition Data database indicated that the fatigue-sensitive subjects ingested fewer 
calories (Figure 2A) and a greater percentage of their total caloric intake was derived from 
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carbohydrates (47%; Figure 2 B). Interestingly, half of the identified significant urinary 
metabolites in the fatigue-sensitive group may be linked to this observed higher percentage of 
dietary intake being derived from carbohydrates. 
 
Alanine is a nonessential amino acid that can be formed in the body from the conversion of 
carbohydrate pyruvate (generated via the glucose-alanine cycle). Therefore, alanine plays an 
important role in, and in the regulation of, glucose metabolism. Since alanine levels parallel 
glucose levels in the blood, significantly increased levels of alanine observed in the urine of the 
fatigue-sensitive group in the present study may be attributed to their higher dietary carbohydrate 
intake. This is partially supported by the observation that urinary pyruvate (an intermediate 
product in the alanine-glucose cycle) was also found to be elevated in the fatigue-sensitive group 
when compared to the fatigue-resistant group, but was not statistically significant (Table 2). 
However, pyruvate was one of the original 23 metabolites identified by OPLS-DA to be 
responsible for group classification (Table 2). 
 
Previous studies have shown that methyl esters of succinate are potent insulin secretagogues in 
pancreatic β-cells (MacDonald, 1993; MacDonald and Fahein, 1988). Once taken-up by the cell, 
these esters of succinate are hydrolyzed intracellularly to succinate. Initiation of insulin release 
by esterified succinate, and not by other esters of TCA intermediates, indicates that 
mitochondrial metabolism alone is sufficient to initiate insulin release (MacDonald and Fahein, 
1988).  2,2-Dimethylsuccinate is a nutrient secretagogue that has been shown to be as effective 
as glucose in stimulating insulin release from the pancreas (Fahien and MacDonald, 2002).  Its 
significant elevation in the urine of the fatigue-sensitive group is suggestive of greater 
carbohydrate ingestion and metabolism. 
 
Taurine, a sulfur amino acid, has many diverse biological functions (i.e. brain inhibitory 
neurotransmitter, cell membrane stabilizer, ion transport facilitator, etc.). One of the important 
functions of taurine is to reduce blood sugar. Studies involving diabetic rat strains have shown 
that taurine significantly reduces weight and blood sugar in these animal models (Pop-Busui et 
al., 2001; Nakaya et al., 2000). Taurine has been shown to act as a glycation inhibitor, resulting 
in decreased formation of advanced glycation end products, both in vitro and in vivo (Huang et 
al., 2008; Verzola et al., 2002). Therefore, it is possible that the significantly elevated level of 
taurine found in the urine of the fatigue-sensitive group is a response to increased blood glucose 
levels due to high carbohydrate ingestion. Although taurine can be obtained from the diet by 
ingestion of protein, it can also be synthesized in adult humans. Therefore it is also possible that 
the elevated taurine levels observed in the fatigue-sensitive group may have been due to 
synthesis in response to high carbohydrate intake. Taurine has been shown to be synthesized and 
stored in adipocytes by two cellular pathways (Ueki and Stipanuk, 2009). 
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The role of the remaining three significantly elevated urinary metabolites, with regards to fatigue 
sensitivity, is not clear. Tyramine (metabolite of tyrosine), trimethylamine (TMA) and N- 
methylnicotinate (NMN) are metabolites more likely to have been obtained from the diet and, 
with the exception of tyramine, are plant-based metabolites. Tyamine, a monoamine, is found in 
foods as the result of tyrosine decarboxylation during fermentation. NMN (or trigonelline) is an 
alkaloid found in a wide variety of plants and in coffee. However, NMN is an important dietary 
betaine. Trimethylamine is a product of decomposition and is derived from gut microflora. 
Although these metabolites do not appear to have a link to a specific biochemical pathway of 
mammalian metabolism linked to fatigue, significant changes in methylamine (TMA) and 
nucleotide (NMN) metabolism have been observed in type 2 diabetes in both rodent and human 
models (Salek et al., 2007). 
 
 
6.0 CONCLUSIONS 
 
The results of the present study demonstrated that NMR-based metabolomics could be used as a 
noninvasive approach to predict and characterize sleep deprivation-induced fatigue impact on 
cognitive performance. Furthermore, our results indicated that NMR-based metabolomics 
analysis of human urine identified changes in urinary metabolite profiles that corresponded to 
psychological testing scores of cognitive performance under sleep deprivation-induced fatigue. 
More importantly, NMR-based metabolomics was also capable of predicting susceptibility to 
sleep-deprivation-induced fatigue 12 hours prior to the 24 hour cognitive testing phase of the 
study. Elevated levels of tyrosine, HV and 3-HI in the urine of the fatigue-resistant subjects 
suggest that enhanced cognitive performance under sleep deprivation-induced fatigue may have 
been due to increased protein intake prior to the start of the cognitive testing phase of the study 
(see Figure 1). A protein-rich diet can lead to activation of the dopaminergic pathway via 
increased plasma tyrosine levels following protein digestion. This was partially supported in the 
present study by the observation that nutritional analysis of subject food logs 8 h prior to the start 
of the cognitive testing phase of the study indicated that the fatigue-resistant subjects ingested a 
significant 2-fold higher amount of protein than the fatigue-sensitive subjects. A number of 
studies have shown the benefits of dietary protein and tyrosine supplementation on improving 
cognitive function (Fischer et al., 2001 and 2002; Dye et al., 2000; Lieberman, 2003). Military 
studies from all three US services, and one European military study, have all reported positive 
findings for tyrosine with regards to enhanced cognitive performance. In addition to the above 
findings, three of the significant metabolites that were found to be elevated in the urine of the 
fatigue-sensitive subjects (taurine, alanine and 2,2-dimethylsuccinate) were strongly associated 
with a high carbohydrate diet. 
 
Taken together, the collection of six identified urinary metabolites (tyrosine, HV, 3-HI, taurine, 
alanine and 2,2-dimethylsuccinate) may provide a useful subset of urinary metabolite markers to 
screen, or select, personnel for demanding missions where fatigue is expected to play a role. It is 
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possible that future identification of the five significant unidentified metabolites using 2D NMR 
may result in an expansion of the number of metabolites used for personnel mission readiness 
screening. 
 
The results of this study also raise the issue of adequate nutrition for optimal performance. Based 
on analysis of the study food logs, it was apparent from visual inspection of the food logs that a 
number of service members were making poor choices with regards to food selection. This was 
later verified by the study dietitian using the Nutrition Data analysis of the food logs. The study 
results also indicated that nutritional education of young service men and women may be 
necessary as part of their training. Particular attention should be paid to assuring that proper 
nutritional requirements are being met prior to, during and following missions to maintaining 
optimal physical and cognitive performance readiness. 
 
Although the previous technical report attributed increased cognitive performance at the end of 
the sleep-deprivation study due to a psychological “going home” effect, our data suggest that this 
phenomenon may have resulted due to changes in nutritional status. There has been a growing 
interest in the potential effects of food on various aspects of psychological state, and mental and 
physical performance (Dye et al., 2000). All of the subjects ate the standard diet provided (Table 
1) during the 24 h cognitive testing portion of the study. Thus, any nutritional deficiencies prior 
to the cognitive testing phase of the study would progressively be reversed during the 24 h 
course of cognitive testing, and may explain the increase in cognitive performance observed at 
the end of the 36 h sleep deprivation-induced fatigue testing. This was partially supported by the 
finding that NMR urinary profiles obtained from the fatigue-resistant and fatigue-sensitive study 
subjects began to overlap at this time point and appeared to be more representative of their pre- 
testing profiles at 0 h (Figure 8). 
 
It is important to note that this study was not designed as a nutritional investigation into the 
effects of macronutrients on cognitive performance, but that NMR data analysis of urine from 
sleep-deprived subjects indicated that nutrient metabolites seemed to play a role in the 
classification of subject cognitive performance outcome under this condition of induced fatigue. 
Therefore, care should be taken when considering the interpretation of the current study results 
due to the low sample size (N-value) commonly seen with these types of studies. We attempted 
to control as many confounding factors as possible, such as dietary, pharmacological, alcohol 
and smoking restrictions, overnight fasting, maintenance of food logs, gender, and timing of all 
meals. However, other numerous factors exist (e.g. age, ethnicity, underlying medical issues, 
susceptibility to stress, etc.). Additional work with macronutrients, especially carbohydrate, and 
diets that vary in protein to carbohydrate ratio, is also necessary. In general, little work on the 
effects of dietary constituents in mixed diets has been conducted and their chronic effects on 
behavior have not been investigated. Such studies would be of great value, not only to address 
military requirements, but for the civilian population as well. Further research is required to 
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elucidate the specificity of the mechanisms involved in the effects of macronutrients on mental 
performance. 
 
Currently, objective biomarkers of fatigue are based on difficult to interpret and frequently 
burdensome electrophysiologic or behavioral tests (e.g. multiple sleep latency test, PVT and 
pupillometry). Although these tests have been shown to be practical for scientific investigations, 
they are difficult to use in field studies and would have little useful application in military 
operational environments. To date, no reliable biomarkers of fatigue have been developed. 
However, there is an important need for this technology. Given the magnitude of the problem of 
sleep deprivation-induced fatigue to the public and the military, this is not surprising. Therefore, 
more engaged basic research is required to address this problem. A general theme that has been 
emerging as a result these types of research efforts is the importance of identifying simple and 
quantifiable biomarkers of fatigue (Jones et al., 2005; Van Dongen et al., 2005; Dawson and 
McCulloch, 2005). The results from this study demonstrated that changes in urinary metabolite 
profiles, using NMR-based metabolomics, were found to correlate with changes in psychological 
testing performance (PVT and ANAM) under conditions of sleep deprivation. The present study 
also provided evidence that metabolomics may be a useful tool for identifying potential 
molecular biomarkers (urinary metabolites) predictive of cognitive performance ability when 
sleep deprived. 
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LIST OF ACRONYMS 
 
 
AFRL Air Force Research Laboratory 
ANAM Automated Neuropsychological Assessment Metrics 
BBB Blood Brain Barrier 
CI Confidence Interval 
CNS Central Nervous System 
CoA Coenzyme A 
CPT Continuous Performance Test 
DOPA Dihydroxyphenylalanine 
EEG Electroencephalography 
3-HI 3-Hydroxyisovalerate 
HMQC Heteronuclear Multiple-Quantum Correlation 
HV Homovanillate 
ICD Informed Consent Document 
LC/MS Liquid Chromatography/Mass Spectroscopy 
NMN N-Methylnicotinate 
NMR Nuclear Magnetic Resonance 
NOES Nuclear Overhauser Effect Spectroscopy 
OPLS-DA Orthogonal Projections onto Latent Structures-Discriminant Analysis 
PC Personal Computer 
PCA Principal Component Analysis 
ppm Parts Per Megahertz 
PQN Probabilistic Quotient Normalization 
PRESS Predicted Residual Sum of Squares 
PVT Psychomotor Vigilance Task 
SEM Standard Error of the Mean 
SSY Sum of Squares “Y” 
TMA Trimethylamine 
TOCSY Total Correlation Spectroscopy 
TSP Trimethylsilylpropionic (2, 2, 3, 3 d4) acid 
WPAFB Wright-Patterson Air Force Base 
